Vimarsana
Biggest News Aggregation in the World

Page 2 - Mindset Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mindset Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mindset Pharma Today - Breaking & Trending Today

Ovid Therapeutics (NASDAQ:OVID) and Mindset Pharma (OTCMKTS:MSSTF) Critical Survey - Vimarsana News

Ovid Therapeutics (NASDAQ:OVID) and Mindset Pharma (OTCMKTS:MSSTF) Critical Survey

Published: September 21, 2023

Ovid Therapeutics (NASDAQ:OVID – Get Free Report) and Mindset Pharma (OTCMKTS:MSSTF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings. Profitability This table compares Ovid Therapeutics and Mindset […]

Source: tickerreport.com
Related Topics:
New YorkUnited StatesMarinus Pharmaceuticals IncNorthwestern UniversityOvid Therapeutics IncMindset Pharma IncOvid TherapeuticsGet Free ReportMindset PharmaGiven Mindset PharmaTherapeutics IncBain SyndromeMarinus PharmaceuticalsOvid Therapeutics DailyNasdaq OvidStock ComparisonStock Analysis
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic - Mindset Pharma (OTC:MSSTF) - Vimarsana News

Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic - Mindset Pharma (OTC:MSSTF)

Published: September 18, 2023

Clinical-stage biopharma company Reunion Neuroscience has received the FDA’s clearance on its Investigational New Drug (IND) application to begin a Phase 2 study of RE104, a novel serotonergic psychedelic compound aimed at treating postpartum depression (PPD.) 

Source: benzinga.com
Related Topics:
Greg MayesReunion NeuroscienceInvestigational New DrugField TripMultiple PatentMindset PharmaTerran Biosciences
The firms hoping to take psychedelic drugs mainstream - Vimarsana News

The firms hoping to take psychedelic drugs mainstream

Published: September 15, 2023

Start-ups are tweaking psychedelic compounds to treat mental health conditions.

Source: bbc.com
Related Topics:
United StatesSan FranciscoDavid OlsonJosh HardmanAndrew KruegelJosh GoldsteinZoe CorbynBeckley PsytechUniversity Of CaliforniaJohns Hopkins UniversityBendable TherapyPsychedelic AlphaMindset PharmaBright MindsKingdom Based Small PharmaUnited Kingdom BasedDelix Therapeutics
The firms hoping to take psychedelic drugs mainstream - Vimarsana News

The firms hoping to take psychedelic drugs mainstream

Published: September 14, 2023

Start-ups are tweaking psychedelic compounds to treat mental health conditions.

Source: yahoo.com
Related Topics:
United StatesJosh GoldsteinDavid OlsonBeckley PsytechJosh HardmanAndrew KruegelJohns Hopkins UniversityUniversity Of CaliforniaBendable TherapyPsychedelic AlphaMindset PharmaBright MindsKingdom Based Small PharmaUnited Kingdom BasedDelix TherapeuticsActive IngredientPsychedelic Trip
The firms hoping to take psychedelic drugs mainstream - Vimarsana News

The firms hoping to take psychedelic drugs mainstream

Published: September 14, 2023

Start-ups are tweaking psychedelic compounds to treat mental health conditions.

Source: bbc.co.uk
Related Topics:
San FranciscoUnited StatesJosh GoldsteinZoe CorbynAndrew KruegelJosh HardmanBeckley PsytechDavid OlsonUniversity Of CaliforniaJohns Hopkins UniversityBendable TherapyPsychedelic AlphaMindset PharmaBright MindsKingdom Based Small PharmaUnited Kingdom BasedDelix Therapeutics